Skip to content

EndoFLIP System

by Crospon, Ltd. 2 variants

510(k) K160725

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK160725 Date1 May 2016ClearedStatusActive

Official records

From the FDA record

Received by the FDA
16 Mar 2016
FDA decision
1 May 2016 (Substantially Equivalent)
FDA review time
46 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K160725 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
EndoFLIP
510(k) Number
FDA product code
FFX
Device class
Class II
Regulation
21 CFR Part 876.1725
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The EndoFLIP System is a Gastrointestinal Motility (Electrical) System designed to measure the functional lumen diameter (FLD) of the gastric stoma in patients with a gastric band. It employs an endoscopically placed, balloon-based catheter to assess the patency and size of the stoma, aiding in the evaluation of gastric band efficacy and patient management.

The device is supplied as a single-use, sterile system and is intended for use in clinical settings such as endoscopy suites. It includes a balloon catheter (e.g., EF-325n, EF-325l) and associated instrumentation for measurement. The EndoFLIP System is classified as a Class II medical device under FDA regulations (21 CFR 876.1725) and has received FDA 510(k) clearance for use in gastroenterology and urology procedures. No MRI safety information is specified.

Similar devices

Other devices filed under FDA product code FFX (System, Gastrointestinal Motility (Electrical)).

Other devices from Crospon, Ltd.

See all devices from Crospon, Ltd. →